HEFCE closed at the end of March 2018. The information on this website is historical and is no longer maintained.
The HEFCE domain - www.hefce.ac.uk - will continue to function until September 2018. At this point we will close the site entirely and all its information will only be available from the National Web Archive.
A joint collaboration between Queen Mary University of London, University College London and King’s College London, the centre aims to capitalise on the academic and commercial expertise to accelerate innovative discovery, translational and clinical research in several biomedical domains.
The centre will support gene-based experimental medicine studies and novel therapeutic validation. It will provide a population-based research and education environment.
Located in the East End of London, at Queen Mary's Whitechapel campus, the centre will add substantial value to established life science resources distributed across the South East of England.
The centre will specifically enable novel genomic-based research and training through the assessment of naturally occurring loss of gene function in humans.
Its main outputs of its activity will be:
Page last updated 23 February 2018